Abstract
Axon loss and neurodegeneration constitute clinically debilitating sequelae in demyelinating diseases such as multiple sclerosis, but the underlying mechanisms of secondary degeneration are not well understood. Myelinating glia play a fundamental role in promoting the maturation of the axon cytoskeleton, regulating axon trafficking parameters, and imposing architectural rearrangements such as the nodes of Ranvier and their associated molecular domains. In the setting of demyelination, these changes may be reversed or persist as maladaptive features, leading to axon degeneration. In this review, we consider recent insights into axon-glial interactions during development and disease to propose that disruption of the cytoskeleton, nodal architecture, and other components of axon infrastructure is a potential mediator of pathophysiological damage after demyelination.
© 2017 Pan and Chan.
Publication types
-
Review
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Axons / metabolism*
-
Axons / pathology
-
Axons / ultrastructure
-
Cell Adhesion Molecules, Neuronal / genetics
-
Cell Adhesion Molecules, Neuronal / metabolism
-
Contactin 1 / genetics
-
Contactin 1 / metabolism
-
Cytoskeleton / metabolism*
-
Cytoskeleton / pathology
-
Cytoskeleton / ultrastructure
-
Demyelinating Diseases / genetics
-
Demyelinating Diseases / metabolism*
-
Demyelinating Diseases / pathology
-
Gene Expression Regulation
-
Humans
-
Ion Channels / genetics
-
Ion Channels / metabolism
-
Mice
-
Myelin Sheath / metabolism*
-
Myelin Sheath / pathology
-
Myelin Sheath / ultrastructure
-
Neurodegenerative Diseases / genetics
-
Neurodegenerative Diseases / metabolism*
-
Neurodegenerative Diseases / pathology
-
Signal Transduction
-
Spectrin / genetics
-
Spectrin / metabolism
Substances
-
Cell Adhesion Molecules, Neuronal
-
Cntn1 protein, mouse
-
Cntnap1 protein, mouse
-
Contactin 1
-
Ion Channels
-
Spectrin